ReP USP - Resultado da busca

Artigo de periodico
The anticancer potential of kaempferol: a systematic review based on in vitro studies (2024)
Morais, Everton Freitas de ; Oliveira, Lilianny Querino Rocha de ; Morais, Hannah Gil de Farias ; Medeiros, Maurília Raquel de Souto ; Freitas, Roseana de Almeida ; Rodini, Camila de Oliveira ; Coletta, Ricardo Della
Source: Cancers. Unidade: FOB
Subjects: QUIMIOTERÁPICOS, PRODUTOS NATURAIS, FLAVONOIDES, USOS TERAPÊUTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAIS, Everton Freitas de et al. The anticancer potential of kaempferol: a systematic review based on in vitro studies. Cancers, v. 16, n. 3, 2024Tradução . . Disponível em: https://doi.org/10.3390/cancers16030585. Acesso em: 18 nov. 2024.
APA
Morais, E. F. de, Oliveira, L. Q. R. de, Morais, H. G. de F., Medeiros, M. R. de S., Freitas, R. de A., Rodini, C. de O., & Coletta, R. D. (2024). The anticancer potential of kaempferol: a systematic review based on in vitro studies. Cancers, 16( 3). doi:10.3390/cancers16030585
NLM
Morais EF de, Oliveira LQR de, Morais HG de F, Medeiros MR de S, Freitas R de A, Rodini C de O, Coletta RD. The anticancer potential of kaempferol: a systematic review based on in vitro studies [Internet]. Cancers. 2024 ; 16( 3):[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers16030585
Vancouver
Morais EF de, Oliveira LQR de, Morais HG de F, Medeiros MR de S, Freitas R de A, Rodini C de O, Coletta RD. The anticancer potential of kaempferol: a systematic review based on in vitro studies [Internet]. Cancers. 2024 ; 16( 3):[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers16030585
Artigo de periodico-carta/editorial
Translational and comparative research on innovative anti-cancer therapies [Editorial] (2023)
Queiroga, Felisbina ; Cogliati, Bruno
Source: Cancers. Unidade: FMVZ
Subjects: NEOPLASIAS, ONCOLOGIA VETERINÁRIA, ONCOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
QUEIROGA, Felisbina e COGLIATI, Bruno. Translational and comparative research on innovative anti-cancer therapies [Editorial]. Cancers. Basel: Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo. Disponível em: https://doi.org/10.3390/cancers15041335. Acesso em: 18 nov. 2024. , 2023
APA
Queiroga, F., & Cogliati, B. (2023). Translational and comparative research on innovative anti-cancer therapies [Editorial]. Cancers. Basel: Faculdade de Medicina Veterinária e Zootecnia, Universidade de São Paulo. doi:10.3390/cancers15041335
NLM
Queiroga F, Cogliati B. Translational and comparative research on innovative anti-cancer therapies [Editorial] [Internet]. Cancers. 2023 ; 15( 4): 1-3.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers15041335
Vancouver
Queiroga F, Cogliati B. Translational and comparative research on innovative anti-cancer therapies [Editorial] [Internet]. Cancers. 2023 ; 15( 4): 1-3.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers15041335
Artigo de periodico
Inhibitory effects of alpha-connexin carboxyl-terminal peptide on canine mammary epithelial cells: a study on benign and malignant phenotypes (2023)
Fonseca, Ivone Izabel Mackowiak da ; Nagamine, Márcia Kazumi ; Sato, Ayami ; Rossatto Junior, Carlos Alberto ; Yeh, Elizabeth Shinmay; Dagli, Maria Lúcia Zaidan
Source: Cancers. Unidade: FMVZ
Subjects: CÃES, CONEXINAS, NEOPLASIAS MAMÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FONSECA, Ivone Izabel Mackowiak da et al. Inhibitory effects of alpha-connexin carboxyl-terminal peptide on canine mammary epithelial cells: a study on benign and malignant phenotypes. Cancers, v. 16, n. 4, p. 1-19, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers16040820. Acesso em: 18 nov. 2024.
APA
Fonseca, I. I. M. da, Nagamine, M. K., Sato, A., Rossatto Junior, C. A., Yeh, E. S., & Dagli, M. L. Z. (2023). Inhibitory effects of alpha-connexin carboxyl-terminal peptide on canine mammary epithelial cells: a study on benign and malignant phenotypes. Cancers, 16( 4), 1-19. doi:10.3390/cancers16040820
NLM
Fonseca IIM da, Nagamine MK, Sato A, Rossatto Junior CA, Yeh ES, Dagli MLZ. Inhibitory effects of alpha-connexin carboxyl-terminal peptide on canine mammary epithelial cells: a study on benign and malignant phenotypes [Internet]. Cancers. 2023 ; 16( 4): 1-19.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers16040820
Vancouver
Fonseca IIM da, Nagamine MK, Sato A, Rossatto Junior CA, Yeh ES, Dagli MLZ. Inhibitory effects of alpha-connexin carboxyl-terminal peptide on canine mammary epithelial cells: a study on benign and malignant phenotypes [Internet]. Cancers. 2023 ; 16( 4): 1-19.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers16040820
Artigo de periodico
Anthocyanins reduce cell invasion and migration through Akt/mTOR downregulation and apoptosis activation in triple-negative breast cancer cells: a systematic review and meta-analysis (2023)
Rabelo, Ana Carolina Silveira ; Guerreiro, Caroline de Aquino ; Shinzato, Vivian Izumi; Ong, Thomas Prates ; Noratto, Giuliana
Source: Cancers. Unidade: FCF
Subjects: NEOPLASIAS MAMÁRIAS, CEREJA, ARROZ, PRODUTOS NATURAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RABELO, Ana Carolina Silveira et al. Anthocyanins reduce cell invasion and migration through Akt/mTOR downregulation and apoptosis activation in triple-negative breast cancer cells: a systematic review and meta-analysis. Cancers, v. 15, p. 1-13 art. 2300, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15082300. Acesso em: 18 nov. 2024.
APA
Rabelo, A. C. S., Guerreiro, C. de A., Shinzato, V. I., Ong, T. P., & Noratto, G. (2023). Anthocyanins reduce cell invasion and migration through Akt/mTOR downregulation and apoptosis activation in triple-negative breast cancer cells: a systematic review and meta-analysis. Cancers, 15, 1-13 art. 2300. doi:10.3390/cancers15082300
NLM
Rabelo ACS, Guerreiro C de A, Shinzato VI, Ong TP, Noratto G. Anthocyanins reduce cell invasion and migration through Akt/mTOR downregulation and apoptosis activation in triple-negative breast cancer cells: a systematic review and meta-analysis [Internet]. Cancers. 2023 ; 15 1-13 art. 2300.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers15082300
Vancouver
Rabelo ACS, Guerreiro C de A, Shinzato VI, Ong TP, Noratto G. Anthocyanins reduce cell invasion and migration through Akt/mTOR downregulation and apoptosis activation in triple-negative breast cancer cells: a systematic review and meta-analysis [Internet]. Cancers. 2023 ; 15 1-13 art. 2300.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers15082300
Artigo de periodico
Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial (2023)
Lepski, Guilherme ; Bergami-Santos, Patricia C. ; Pinho, Mariana P. ; Chauca-Torres, Nadia E. ; Evangelista, Gabriela C. M. ; Teixeira, Sarah F. ; Flatow, Elizabeth ; Oliveira, Jaqueline V. de ; Fogolin, Carla ; Peres, Nataly ; Arévalo, Analía ; Alves, Venâncio A. F. ; Barbuto, José Alexandre Marzagão
Source: Cancers. Unidades: FM, ICB
Subjects: IMUNOLOGIA, NEOPLASIAS CEREBRAIS, GLIOMA, IMUNOTERAPIA, ADJUVANTES IMUNOLÓGICOS, CÉLULAS DENDRÍTICAS, ASTROCITOMA, CÉLULAS CULTIVADAS DE TUMOR, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEPSKI, Guilherme et al. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial. Cancers, v. 15, n. 4, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15041239. Acesso em: 18 nov. 2024.
APA
Lepski, G., Bergami-Santos, P. C., Pinho, M. P., Chauca-Torres, N. E., Evangelista, G. C. M., Teixeira, S. F., et al. (2023). Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial. Cancers, 15( 4), 1-12. doi:10.3390/cancers15041239
NLM
Lepski G, Bergami-Santos PC, Pinho MP, Chauca-Torres NE, Evangelista GCM, Teixeira SF, Flatow E, Oliveira JV de, Fogolin C, Peres N, Arévalo A, Alves VAF, Barbuto JAM. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial [Internet]. Cancers. 2023 ; 15( 4): 1-12.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers15041239
Vancouver
Lepski G, Bergami-Santos PC, Pinho MP, Chauca-Torres NE, Evangelista GCM, Teixeira SF, Flatow E, Oliveira JV de, Fogolin C, Peres N, Arévalo A, Alves VAF, Barbuto JAM. Adjuvant vaccination with allogenic dendritic cells significantly prolongs overall survival in high-grade gliomas: results of a phase II trial [Internet]. Cancers. 2023 ; 15( 4): 1-12.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers15041239
Artigo de periodico
Acute Myeloid Leukemia expresses a specific group of olfactory receptors (2023)
Guardia, Gabriela D. A; Naressi, Rafaella G ; Buzzato, Vanessa C; Costa, Juliana B. da; Zalcberg, Ilana; Ramires, Jordana; Malnic, Bettina ; Gutiyama, Luciana M; Galante, Pedro A. F.
Source: Cancers. Unidade: IQ
Subjects: LEUCEMIA MIELOIDE AGUDA, BIOMARCADORES, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUARDIA, Gabriela D. A et al. Acute Myeloid Leukemia expresses a specific group of olfactory receptors. Cancers, v. 15, p. 1-21 art. 3073, 2023Tradução . . Disponível em: https://doi.org/10.3390/cancers15123073. Acesso em: 18 nov. 2024.
APA
Guardia, G. D. A., Naressi, R. G., Buzzato, V. C., Costa, J. B. da, Zalcberg, I., Ramires, J., et al. (2023). Acute Myeloid Leukemia expresses a specific group of olfactory receptors. Cancers, 15, 1-21 art. 3073. doi:10.3390/cancers15123073
NLM
Guardia GDA, Naressi RG, Buzzato VC, Costa JB da, Zalcberg I, Ramires J, Malnic B, Gutiyama LM, Galante PAF. Acute Myeloid Leukemia expresses a specific group of olfactory receptors [Internet]. Cancers. 2023 ; 15 1-21 art. 3073.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers15123073
Vancouver
Guardia GDA, Naressi RG, Buzzato VC, Costa JB da, Zalcberg I, Ramires J, Malnic B, Gutiyama LM, Galante PAF. Acute Myeloid Leukemia expresses a specific group of olfactory receptors [Internet]. Cancers. 2023 ; 15 1-21 art. 3073.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers15123073
Artigo de periodico
Vet-ICD-O-Canine-1, a system for coding canine neoplasms based on the human ICD-O-3.2 (2022)
Pinello, Katia ; Baldassarre, Valeria ; Steiger, Katja ; Paciello, Orlando; Pires, Isabel ; Laufer-Amorim, Renée ; Oevermann, Anna ; Niza-Ribeiro, João ; Aresu, Luca ; Rous, Brian ; Znaor, Ariana; Cree, Ian A; Guscetti, Franco ; Palmieri, Chiara ; Dagli, Maria Lúcia Zaidan
Source: Cancers. Unidade: FMVZ
Subjects: CÃES, NEOPLASIAS EM ANIMAL, REGISTROS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PINELLO, Katia et al. Vet-ICD-O-Canine-1, a system for coding canine neoplasms based on the human ICD-O-3.2. Cancers, v. 14, n. 6, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14061529. Acesso em: 18 nov. 2024.
APA
Pinello, K., Baldassarre, V., Steiger, K., Paciello, O., Pires, I., Laufer-Amorim, R., et al. (2022). Vet-ICD-O-Canine-1, a system for coding canine neoplasms based on the human ICD-O-3.2. Cancers, 14( 6), 1-14. doi:10.3390/cancers14061529
NLM
Pinello K, Baldassarre V, Steiger K, Paciello O, Pires I, Laufer-Amorim R, Oevermann A, Niza-Ribeiro J, Aresu L, Rous B, Znaor A, Cree IA, Guscetti F, Palmieri C, Dagli MLZ. Vet-ICD-O-Canine-1, a system for coding canine neoplasms based on the human ICD-O-3.2 [Internet]. Cancers. 2022 ; 14( 6): 1-14.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers14061529
Vancouver
Pinello K, Baldassarre V, Steiger K, Paciello O, Pires I, Laufer-Amorim R, Oevermann A, Niza-Ribeiro J, Aresu L, Rous B, Znaor A, Cree IA, Guscetti F, Palmieri C, Dagli MLZ. Vet-ICD-O-Canine-1, a system for coding canine neoplasms based on the human ICD-O-3.2 [Internet]. Cancers. 2022 ; 14( 6): 1-14.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers14061529
Artigo de periodico
A stochastic binary model for the regulation of gene expression to investigate responses to gene therapy (2022)
Giovanini, Guilherme ; Barros, Luciana R. C. ; Gama, Leonardo R. ; Tortelli Junior, Tharcisio Citrangulo ; Ramos, Alexandre Ferreira
Source: Cancers. Unidades: EACH, FM
Subjects: NEOPLASIAS, BIOLOGIA MOLECULAR, REGULAÇÃO GÊNICA, EXPRESSÃO GÊNICA, DINÂMICA ESTOCÁSTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIOVANINI, Guilherme et al. A stochastic binary model for the regulation of gene expression to investigate responses to gene therapy. Cancers, v. 14, n. Ja 2022, p. 01-29, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14030633. Acesso em: 18 nov. 2024.
APA
Giovanini, G., Barros, L. R. C., Gama, L. R., Tortelli Junior, T. C., & Ramos, A. F. (2022). A stochastic binary model for the regulation of gene expression to investigate responses to gene therapy. Cancers, 14( Ja 2022), 01-29. doi:10.3390/cancers14030633
NLM
Giovanini G, Barros LRC, Gama LR, Tortelli Junior TC, Ramos AF. A stochastic binary model for the regulation of gene expression to investigate responses to gene therapy [Internet]. Cancers. 2022 ; 14( Ja 2022): 01-29.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers14030633
Vancouver
Giovanini G, Barros LRC, Gama LR, Tortelli Junior TC, Ramos AF. A stochastic binary model for the regulation of gene expression to investigate responses to gene therapy [Internet]. Cancers. 2022 ; 14( Ja 2022): 01-29.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers14030633
Artigo de periodico
Aerobic exercise training and in vivo akt activation counteract cancer cachexia by inducing a hypertrophic profile through eIF-2α modulation (2022)
Pereira, Marcelo Gomes ; Voltarelli, Vanessa Azevedo ; Tobias, Gabriel Cardial ; Souza, Lara de; Borges, Gabriela Silva ; Paixão, Ailma Oliveira da ; Bowen, Thomas Scott; Demasi, Marilene ; Miyabara, Elen Haruka ; Brum, Patricia Chakur
Source: Cancers. Unidades: EEFE, ICB
Subjects: ANATOMIA, EXERCÍCIO FÍSICO, CAQUEXIA, MÚSCULO ESQUELÉTICO, PERDA DE MASSA, PERDA DE PESO, COMORBIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Marcelo Gomes et al. Aerobic exercise training and in vivo akt activation counteract cancer cachexia by inducing a hypertrophic profile through eIF-2α modulation. Cancers, v. 14, n. 1, p. 1-20, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14010028. Acesso em: 18 nov. 2024.
APA
Pereira, M. G., Voltarelli, V. A., Tobias, G. C., Souza, L. de, Borges, G. S., Paixão, A. O. da, et al. (2022). Aerobic exercise training and in vivo akt activation counteract cancer cachexia by inducing a hypertrophic profile through eIF-2α modulation. Cancers, 14( 1), 1-20. doi:10.3390/cancers14010028
NLM
Pereira MG, Voltarelli VA, Tobias GC, Souza L de, Borges GS, Paixão AO da, Bowen TS, Demasi M, Miyabara EH, Brum PC. Aerobic exercise training and in vivo akt activation counteract cancer cachexia by inducing a hypertrophic profile through eIF-2α modulation [Internet]. Cancers. 2022 ; 14( 1): 1-20.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers14010028
Vancouver
Pereira MG, Voltarelli VA, Tobias GC, Souza L de, Borges GS, Paixão AO da, Bowen TS, Demasi M, Miyabara EH, Brum PC. Aerobic exercise training and in vivo akt activation counteract cancer cachexia by inducing a hypertrophic profile through eIF-2α modulation [Internet]. Cancers. 2022 ; 14( 1): 1-20.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers14010028
Artigo de periodico
Proteases and HPV-induced carcinogenesis (2022)
Vieira, Gabriel Viliod ; Santos, Fernanda Somera dos ; Lepique, Ana Paula ; Fonseca, Carol Kobori da ; Innocentini, Lara Maria Alencar Ramos ; Silva, Paulo Henrique Braz ; Quintana, Silvana Maria ; Sales, Katiuchia Uzzun
Source: Cancers. Unidades: ICB, FMRP, FO
Subjects: IMUNOLOGIA, INFECÇÕES POR PAPILLOMAVIRUS, INFECÇÕES POR VÍRUS DE DNA, CARCINOGÊNESE, ENZIMAS PROTEOLÍTICAS, ATIVAÇÃO ENZIMÁTICA, NEOPLASIAS DO COLO UTERINO, NEOPLASIAS OROFARÍNGEAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Gabriel Viliod et al. Proteases and HPV-induced carcinogenesis. Cancers, v. 14, n. 13, p. 1-25, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14133038. Acesso em: 18 nov. 2024.
APA
Vieira, G. V., Santos, F. S. dos, Lepique, A. P., Fonseca, C. K. da, Innocentini, L. M. A. R., Silva, P. H. B., et al. (2022). Proteases and HPV-induced carcinogenesis. Cancers, 14( 13), 1-25. doi:10.3390/cancers14133038
NLM
Vieira GV, Santos FS dos, Lepique AP, Fonseca CK da, Innocentini LMAR, Silva PHB, Quintana SM, Sales KU. Proteases and HPV-induced carcinogenesis [Internet]. Cancers. 2022 ; 14( 13): 1-25.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers14133038
Vancouver
Vieira GV, Santos FS dos, Lepique AP, Fonseca CK da, Innocentini LMAR, Silva PHB, Quintana SM, Sales KU. Proteases and HPV-induced carcinogenesis [Internet]. Cancers. 2022 ; 14( 13): 1-25.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers14133038
Artigo de periodico
Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms (2022)
Vicari, Hugo Passos ; Lima, Keli Cristina de ; Costa-Lotufo, Letícia Veras ; Machado Neto, João Agostinho
Source: Cancers. Unidades: ICB, FM
Subjects: FARMACOLOGIA, LEUCEMIA, ANTINEOPLÁSICOS, MICROTÚBULOS, LEUCÓCITOS, GLICOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VICARI, Hugo Passos et al. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms. Cancers, v. 14, n. 24, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14246080. Acesso em: 18 nov. 2024.
APA
Vicari, H. P., Lima, K. C. de, Costa-Lotufo, L. V., & Machado Neto, J. A. (2022). Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms. Cancers, 14( 24), 1-15. doi:10.3390/cancers14246080
NLM
Vicari HP, Lima KC de, Costa-Lotufo LV, Machado Neto JA. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms [Internet]. Cancers. 2022 ; 14( 24): 1-15.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers14246080
Vancouver
Vicari HP, Lima KC de, Costa-Lotufo LV, Machado Neto JA. Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms [Internet]. Cancers. 2022 ; 14( 24): 1-15.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers14246080
Artigo de periodico
Unraveling the risk factors and etiology of the canine oral mucosal melanoma: results of an epidemiological questionnaire, oral microbiome analysis and investigation of papillomavirus infection (2022)
Carvalho, Joyce Pires de ; Carrilho, Marcella Collaneri; Anjos, Denner Santos dos ; Hernandez, Carolina Dagli ; Sichero, Laura ; Dagli, Maria Lúcia Zaidan
Source: Cancers. Unidades: FMVZ, FCF
Subjects: MELANOMA ANIMAL, PAPILLOMAVIRUS, CÃES, NEOPLASIAS OROFARÍNGEAS, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Joyce Pires de et al. Unraveling the risk factors and etiology of the canine oral mucosal melanoma: results of an epidemiological questionnaire, oral microbiome analysis and investigation of papillomavirus infection. Cancers, v. 14, n. 14, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14143397. Acesso em: 18 nov. 2024.
APA
Carvalho, J. P. de, Carrilho, M. C., Anjos, D. S. dos, Hernandez, C. D., Sichero, L., & Dagli, M. L. Z. (2022). Unraveling the risk factors and etiology of the canine oral mucosal melanoma: results of an epidemiological questionnaire, oral microbiome analysis and investigation of papillomavirus infection. Cancers, 14( 14), 1-15. doi:10.3390/cancers14143397
NLM
Carvalho JP de, Carrilho MC, Anjos DS dos, Hernandez CD, Sichero L, Dagli MLZ. Unraveling the risk factors and etiology of the canine oral mucosal melanoma: results of an epidemiological questionnaire, oral microbiome analysis and investigation of papillomavirus infection [Internet]. Cancers. 2022 ; 14( 14): 1-15.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers14143397
Vancouver
Carvalho JP de, Carrilho MC, Anjos DS dos, Hernandez CD, Sichero L, Dagli MLZ. Unraveling the risk factors and etiology of the canine oral mucosal melanoma: results of an epidemiological questionnaire, oral microbiome analysis and investigation of papillomavirus infection [Internet]. Cancers. 2022 ; 14( 14): 1-15.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers14143397
Artigo de periodico
Gene editing with CRISPR/Cas methodology and thyroid cancer: where are we? (2022)
Fuziwara, Cesar Seigi ; Mello, Diego Claro de ; Kimura, Edna Teruko
Source: Cancers. Unidade: ICB
Subjects: BIOLOGIA CELULAR, NEOPLASIAS DA TIREOIDE, CÉLULAS CULTIVADAS DE TUMOR, GENES, GENES, GENOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUZIWARA, Cesar Seigi e MELLO, Diego Claro de e KIMURA, Edna Teruko. Gene editing with CRISPR/Cas methodology and thyroid cancer: where are we?. Cancers, v. 14, n. 3, p. 1-21, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14030844. Acesso em: 18 nov. 2024.
APA
Fuziwara, C. S., Mello, D. C. de, & Kimura, E. T. (2022). Gene editing with CRISPR/Cas methodology and thyroid cancer: where are we? Cancers, 14( 3), 1-21. doi:10.3390/cancers14030844
NLM
Fuziwara CS, Mello DC de, Kimura ET. Gene editing with CRISPR/Cas methodology and thyroid cancer: where are we? [Internet]. Cancers. 2022 ; 14( 3): 1-21.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers14030844
Vancouver
Fuziwara CS, Mello DC de, Kimura ET. Gene editing with CRISPR/Cas methodology and thyroid cancer: where are we? [Internet]. Cancers. 2022 ; 14( 3): 1-21.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers14030844
Artigo de periodico
Reproducibility of gene expression signatures in diffuse large B-cell lymphoma (2022)
Plaça, Jessica Rodrigues; Diepstra, Arjan; Los, Tjitske; Mendeville, Matías; Seitz, Annika; Lugtenburg, Pieternella J.; Zijlstra, Josée; Lam, King; Silva Junior, Wilson Araújo da ; Ylstra, Bauke; Jong, Daphne de; Berg, Anke van den; Nijland, Marcel
Source: Cancers. Unidade: FMRP
Subjects: LINFOMA, EXPRESSÃO GÊNICA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PLAÇA, Jessica Rodrigues et al. Reproducibility of gene expression signatures in diffuse large B-cell lymphoma. Cancers, v. 14, n. 5, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.3390/cancers14051346. Acesso em: 18 nov. 2024.
APA
Plaça, J. R., Diepstra, A., Los, T., Mendeville, M., Seitz, A., Lugtenburg, P. J., et al. (2022). Reproducibility of gene expression signatures in diffuse large B-cell lymphoma. Cancers, 14( 5), 1-15. doi:10.3390/cancers14051346
NLM
Plaça JR, Diepstra A, Los T, Mendeville M, Seitz A, Lugtenburg PJ, Zijlstra J, Lam K, Silva Junior WA da, Ylstra B, Jong D de, Berg A van den, Nijland M. Reproducibility of gene expression signatures in diffuse large B-cell lymphoma [Internet]. Cancers. 2022 ; 14( 5): 1-15.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers14051346
Vancouver
Plaça JR, Diepstra A, Los T, Mendeville M, Seitz A, Lugtenburg PJ, Zijlstra J, Lam K, Silva Junior WA da, Ylstra B, Jong D de, Berg A van den, Nijland M. Reproducibility of gene expression signatures in diffuse large B-cell lymphoma [Internet]. Cancers. 2022 ; 14( 5): 1-15.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers14051346
Artigo de periodico
gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly (2021)
Wildemberg, Luiz Eduardo; Henriques, Daniel; Elias, Paula Conde Lamparelli; Lima, Carlos Henrique de A.; Musolino, Nina R. de Castro; Camacho, Aline Helen Silva; Faria, Olivia; Nazato, Debora; Abucham, Julio; Vilar, Lucio; Mota, Jose Italo; Huayllas, Martha Katherine P.; Chimelli, Leila; Castro, Margaret de ; Kasuki, Leandro; Gadelha, Mônica R.
Source: Cancers. Unidade: FMRP
Subjects: MUTAÇÃO GENÉTICA, ACROMEGALIA, SOMATOSTATINA, BIOMARCADORES, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WILDEMBERG, Luiz Eduardo et al. gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly. Cancers, v. 13, n. 19, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.3390/cancers13194857. Acesso em: 18 nov. 2024.
APA
Wildemberg, L. E., Henriques, D., Elias, P. C. L., Lima, C. H. de A., Musolino, N. R. de C., Camacho, A. H. S., et al. (2021). gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly. Cancers, 13( 19), 1-11. doi:10.3390/cancers13194857
NLM
Wildemberg LE, Henriques D, Elias PCL, Lima CH de A, Musolino NR de C, Camacho AHS, Faria O, Nazato D, Abucham J, Vilar L, Mota JI, Huayllas MKP, Chimelli L, Castro M de, Kasuki L, Gadelha MR. gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly [Internet]. Cancers. 2021 ; 13( 19): 1-11.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers13194857
Vancouver
Wildemberg LE, Henriques D, Elias PCL, Lima CH de A, Musolino NR de C, Camacho AHS, Faria O, Nazato D, Abucham J, Vilar L, Mota JI, Huayllas MKP, Chimelli L, Castro M de, Kasuki L, Gadelha MR. gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly [Internet]. Cancers. 2021 ; 13( 19): 1-11.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers13194857
Artigo de periodico
YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells (2021)
Cruzeiro, Gustavo Alencastro Veiga ; Magalhães, Taciani de Almeida; Sousa, Graziella Ribeiro de ; Silva, Ricardo Bonfim; Biagi Junior, Carlos Alberto Oliveira de ; Chagas, Pablo Ferreira das ; Queiroz, Rosane Gomes de Paula; Scrideli, Carlos Alberto ; Tone, Luiz Gonzaga ; Valera, Elvis Terci
Source: Cancers. Unidade: FMRP
Subjects: MEDULOBLASTOMA, GENÔMICA, NEOPLASIAS, BIOMARCADORES, TERAPIA COMBINADA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZEIRO, Gustavo Alencastro Veiga et al. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells. Cancers, v. 13, n. 24, p. 1-11, 2021Tradução . . Disponível em: https://doi.org/10.3390/cancers13246249. Acesso em: 18 nov. 2024.
APA
Cruzeiro, G. A. V., Magalhães, T. de A., Sousa, G. R. de, Silva, R. B., Biagi Junior, C. A. O. de, Chagas, P. F. das, et al. (2021). YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells. Cancers, 13( 24), 1-11. doi:10.3390/cancers13246249
NLM
Cruzeiro GAV, Magalhães T de A, Sousa GR de, Silva RB, Biagi Junior CAO de, Chagas PF das, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells [Internet]. Cancers. 2021 ; 13( 24): 1-11.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers13246249
Vancouver
Cruzeiro GAV, Magalhães T de A, Sousa GR de, Silva RB, Biagi Junior CAO de, Chagas PF das, Queiroz RG de P, Scrideli CA, Tone LG, Valera ET. YAP1 is a potential predictive molecular biomarker for response to SMO inhibitor in medulloblastoma cells [Internet]. Cancers. 2021 ; 13( 24): 1-11.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers13246249
Artigo de periodico
Proteomic analysis identifies FNDC1, A1BG, and antigen processing proteins associated with tumor heterogeneity and malignancy in a canine model of breast cancer (2021)
Cordeiro, Yonara de Gouveia ; Mulder, Leandra M; van Zeijl, René J. M.; Paskoski, Lindsay Baltel; van Veelen, Peter; Ru, Arnoud de; Strefezzi, Ricardo de Francisco ; Heijs, Bram; Fukumasu, Heidge
Source: Cancers. Unidade: FZEA
Subjects: PROTEÔMICA, NEOPLASIAS MAMÁRIAS, CÃES, ONCOLOGIA VETERINÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORDEIRO, Yonara de Gouveia et al. Proteomic analysis identifies FNDC1, A1BG, and antigen processing proteins associated with tumor heterogeneity and malignancy in a canine model of breast cancer. Cancers, v. 13, n. 23, p. 1-17, 2021Tradução . . Disponível em: https://doi.org/10.3390/cancers13235901. Acesso em: 18 nov. 2024.
APA
Cordeiro, Y. de G., Mulder, L. M., van Zeijl, R. J. M., Paskoski, L. B., van Veelen, P., Ru, A. de, et al. (2021). Proteomic analysis identifies FNDC1, A1BG, and antigen processing proteins associated with tumor heterogeneity and malignancy in a canine model of breast cancer. Cancers, 13( 23), 1-17. doi:10.3390/cancers13235901
NLM
Cordeiro Y de G, Mulder LM, van Zeijl RJM, Paskoski LB, van Veelen P, Ru A de, Strefezzi R de F, Heijs B, Fukumasu H. Proteomic analysis identifies FNDC1, A1BG, and antigen processing proteins associated with tumor heterogeneity and malignancy in a canine model of breast cancer [Internet]. Cancers. 2021 ; 13( 23): 1-17.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers13235901
Vancouver
Cordeiro Y de G, Mulder LM, van Zeijl RJM, Paskoski LB, van Veelen P, Ru A de, Strefezzi R de F, Heijs B, Fukumasu H. Proteomic analysis identifies FNDC1, A1BG, and antigen processing proteins associated with tumor heterogeneity and malignancy in a canine model of breast cancer [Internet]. Cancers. 2021 ; 13( 23): 1-17.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers13235901
Artigo de periodico
Mutational signatures driven by epigenetic determinants enable the stratification of patients with gastric cancer for therapeutic intervention (2021)
Buttura, Jaqueline Ramalho; Santos, Monize Nakamoto Provisor; Valieris, Renan; Drummond, Rodrigo Duarte; Defelicibus, Alexandre; Lima, João Paulo; Calsavara, Vinicius Fernando; Freitas, Helano Carioca; Mitrowsky, Rafael Andres Rosales ; Dias-Neto, Emmanuel
Source: Cancers. Unidades: FFCLRP, BIOINFORMÁTICA
Subjects: MUTAÇÃO GENÉTICA, NEOPLASIAS GÁSTRICAS, PROGNÓSTICO, REPARAÇÃO DE DNA, FENÓTIPOS, GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUTTURA, Jaqueline Ramalho et al. Mutational signatures driven by epigenetic determinants enable the stratification of patients with gastric cancer for therapeutic intervention. Cancers, v. 13, n. 3, p. 1-21, 2021Tradução . . Disponível em: https://doi.org/10.3390/cancers13030490. Acesso em: 18 nov. 2024.
APA
Buttura, J. R., Santos, M. N. P., Valieris, R., Drummond, R. D., Defelicibus, A., Lima, J. P., et al. (2021). Mutational signatures driven by epigenetic determinants enable the stratification of patients with gastric cancer for therapeutic intervention. Cancers, 13( 3), 1-21. doi:10.3390/cancers13030490
NLM
Buttura JR, Santos MNP, Valieris R, Drummond RD, Defelicibus A, Lima JP, Calsavara VF, Freitas HC, Mitrowsky RAR, Dias-Neto E. Mutational signatures driven by epigenetic determinants enable the stratification of patients with gastric cancer for therapeutic intervention [Internet]. Cancers. 2021 ; 13( 3): 1-21.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers13030490
Vancouver
Buttura JR, Santos MNP, Valieris R, Drummond RD, Defelicibus A, Lima JP, Calsavara VF, Freitas HC, Mitrowsky RAR, Dias-Neto E. Mutational signatures driven by epigenetic determinants enable the stratification of patients with gastric cancer for therapeutic intervention [Internet]. Cancers. 2021 ; 13( 3): 1-21.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers13030490
Artigo de periodico
Liquid biopsy as a diagnostic and prognostic tool for women and female dogs with breast cancer (2021)
Colombo, Jucimara ; Moschetta-Pinheiro, Marina Gobbe; Novais, Adriana Alonso ; Stoppe, Bruna Ribeiro; Bonini, Enrico Dumbra; Gonçalves, Francine Moraes; Fukumasu, Heidge ; Coutinho, Luiz Lehmann ; Chuffa, Luiz Gustavo de Almeida; Zuccari, Debora Aparecida Pires de Campos
Source: Cancers. Unidades: FZEA, ESALQ
Subjects: VARIAÇÃO GENÉTICA, BIÓPSIA, NEOPLASIAS MAMÁRIAS, SEQUENCIAMENTO GENÉTICO, MULHERES, CADELAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COLOMBO, Jucimara et al. Liquid biopsy as a diagnostic and prognostic tool for women and female dogs with breast cancer. Cancers, v. 13, p. 1-22, 2021Tradução . . Disponível em: https://doi.org/10.3390/cancers13205233. Acesso em: 18 nov. 2024.
APA
Colombo, J., Moschetta-Pinheiro, M. G., Novais, A. A., Stoppe, B. R., Bonini, E. D., Gonçalves, F. M., et al. (2021). Liquid biopsy as a diagnostic and prognostic tool for women and female dogs with breast cancer. Cancers, 13, 1-22. doi:10.3390/cancers13205233
NLM
Colombo J, Moschetta-Pinheiro MG, Novais AA, Stoppe BR, Bonini ED, Gonçalves FM, Fukumasu H, Coutinho LL, Chuffa LG de A, Zuccari DAP de C. Liquid biopsy as a diagnostic and prognostic tool for women and female dogs with breast cancer [Internet]. Cancers. 2021 ; 13 1-22.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers13205233
Vancouver
Colombo J, Moschetta-Pinheiro MG, Novais AA, Stoppe BR, Bonini ED, Gonçalves FM, Fukumasu H, Coutinho LL, Chuffa LG de A, Zuccari DAP de C. Liquid biopsy as a diagnostic and prognostic tool for women and female dogs with breast cancer [Internet]. Cancers. 2021 ; 13 1-22.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers13205233
Artigo de periodico
In vivo and in vitro models of hepatocellular carcinoma: current strategies for translational modeling (2021)
Romualdo, Guilherme Ribeiro; Leroy, Kaat ; Costa, Cícero Júlio Silva ; Prata, Gabriel Bacil ; Vanderborght, Bart; Silva, Tereza Cristina da; Barbisan, Luis Fernando ; Andraus, Wellington ; Devisscher, Lindsey ; Câmara, Niels Olsen Saraiva ; Vinken, Mathieu ; Cogliati, Bruno
Source: Cancers. Unidades: FM, ICB, FMVZ
Subjects: CARCINOMA HEPATOCELULAR, MODELOS ANIMAIS DE DOENÇAS, MODELOS FISIOLÓGICOS, HEPATOPATIAS, CARCINOGÊNESE ANIMAL, MUATAÇÃO GÊNICA, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROMUALDO, Guilherme Ribeiro et al. In vivo and in vitro models of hepatocellular carcinoma: current strategies for translational modeling. Cancers, v. 13, n. 21, p. 1-57, 2021Tradução . . Disponível em: https://doi.org/10.3390/cancers13215583. Acesso em: 18 nov. 2024.
APA
Romualdo, G. R., Leroy, K., Costa, C. J. S., Prata, G. B., Vanderborght, B., Silva, T. C. da, et al. (2021). In vivo and in vitro models of hepatocellular carcinoma: current strategies for translational modeling. Cancers, 13( 21), 1-57. doi:10.3390/cancers13215583
NLM
Romualdo GR, Leroy K, Costa CJS, Prata GB, Vanderborght B, Silva TC da, Barbisan LF, Andraus W, Devisscher L, Câmara NOS, Vinken M, Cogliati B. In vivo and in vitro models of hepatocellular carcinoma: current strategies for translational modeling [Internet]. Cancers. 2021 ; 13( 21): 1-57.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers13215583
Vancouver
Romualdo GR, Leroy K, Costa CJS, Prata GB, Vanderborght B, Silva TC da, Barbisan LF, Andraus W, Devisscher L, Câmara NOS, Vinken M, Cogliati B. In vivo and in vitro models of hepatocellular carcinoma: current strategies for translational modeling [Internet]. Cancers. 2021 ; 13( 21): 1-57.[citado 2024 nov. 18 ] Available from: https://doi.org/10.3390/cancers13215583

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Grupo de pesquisa

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration